Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter

Journal of Medicinal Chemistry
Gregory E AgostonAmy H Newman

Abstract

A series of N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues has been prepared that function as dopamine uptake inhibitors. The N-methylated analogue of this series had a significantly higher affinity for the dopamine transporter than the parent compound, N-methyl-3 alpha- (diphenylmethoxy)tropane (benztropine, Cogentin). Yet like the parent compound, it retained high affinity for muscarinic receptors. A series of N-substituted compounds were prepared from nor-3 alpha-[bis(4'-fluorophenyl)methoxy]tropane via acylation followed by hydride reduction of the amide or by direct alkylation. All compounds containing a basic tropane nitrogen displaced [3H]WIN 35,428 at the dopamine transporter (Ki range = 8.5-634 nM) and blocked dopamine uptake (IC50 range = 10-371 nM) in rat caudate putamen, whereas ligands with a nonbasic nitrogen were virtually inactive. None of the compounds demonstrated high binding affinity at norepinephrine or serotonin transporters. Importantly, a separation of binding affinities for the dopamine transporter versus muscarinic m1 receptors was achieved by substitution of the N-methyl group with other N-alkyl or arylalkyl substituents (eg. n-butyl, allyl, benzyl, 3-phenylpropyl, etc.). Additio...Continue Reading

References

Jul 1, 1991·Trends in Neurosciences·M J KuharJ W Boja
Jan 1, 1992·Journal of Medicinal Chemistry·P AbrahamF I Carroll
Dec 1, 1980·Journal of Pharmaceutical Sciences·N P Peet

❮ Previous
Next ❯

Citations

Jul 20, 2002·Bioorganic & Medicinal Chemistry Letters·Subramaniam AnanthanRichard B Rothman
Jun 12, 2003·Bioorganic & Medicinal Chemistry Letters·Amy Hauck NewmanRobert R Luedtke
Mar 4, 2000·Bioorganic & Medicinal Chemistry Letters·A P TamizA P Kozikowski
Jun 23, 1999·Drug Discovery Today·M P SmithA P Kozikowski
Mar 13, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Sangeeta RajeNatalie D Eddington
Jul 17, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Clara Velázquez-SánchezJuan J Canales
Jun 30, 2012·Addiction Biology·Clara Velázquez-SánchezJuan J Canales
Jun 2, 2009·The Journal of Pharmacology and Experimental Therapeutics·Gianluigi TandaJonathan L Katz
Sep 22, 2010·The Journal of Pharmacology and Experimental Therapeutics·Theresa A KopajticJonathan L Katz
Nov 23, 2010·The Journal of Pharmacology and Experimental Therapeutics·Su-Min LiJonathan L Katz
Aug 17, 2012·The Journal of Pharmacology and Experimental Therapeutics·Maarten E A ReithFranklin A Davis
Nov 7, 2013·The Journal of Pharmacology and Experimental Therapeutics·Takato HiranitaJonathan L Katz
Nov 7, 2013·The Journal of Pharmacology and Experimental Therapeutics·Rajeev I DesaiJonathan L Katz
Aug 26, 2010·The International Journal of Neuropsychopharmacology·Clara Velazquez-SanchezJuan J Canales
Dec 15, 2015·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Myung-Sun KimSung-Rae Cho
Mar 8, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Hai-Ying ZhangZheng-Xiong Xi
Oct 11, 2013·Nature·Vishal A DeshmukhLuke L Lairson
Jan 19, 2019·Acta Neuropathologica Communications·Olivier CerlesFrédéric Batteux
Apr 24, 2012·British Journal of Pharmacology·Stefan Bröer, Ulrik Gether
Jun 28, 2018·The Journal of Pharmacology and Experimental Therapeutics·Weimin C HongJonathan L Katz
Aug 2, 2005·The Journal of Pharmacology and Experimental Therapeutics·Vera C CampbellJonathan L Katz
Feb 3, 2004·The Journal of Pharmacology and Experimental Therapeutics·Jonathan L KatzAmy Hauck Newman
Mar 4, 2005·The Journal of Pharmacology and Experimental Therapeutics·Su-Min LiJonathan L Katz
Jul 15, 2011·Pharmacological Reviews·Anders S KristensenUlrik Gether
Jun 16, 2017·Glia·Katy L H ColeDavid A Lyons

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.